We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+27.71%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$322M
AUM Growth
+$12.3M
Cap. Flow
-$21.1M
Cap. Flow %
-6.55%
Top 10 Hldgs %
61.66%
Holding
80
New
8
Increased
8
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$12.2M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$5.01M
3
DELL icon
Dell
DELL
+$4.09M
4
LRMR icon
Larimar Therapeutics
LRMR
+$3.47M
5
IMRX icon
Immuneering
IMRX
+$2.85M

Top Sells

Rank Stock Value
1
TRML
Tourmaline Bio
TRML
+$15.9M
2
NCDL icon
Nuveen Churchill Direct Lending
NCDL
+$15.2M
3
TEM
Tempus AI
TEM
+$5.09M
4
MLYS icon
Mineralys Therapeutics
MLYS
+$5.08M
5
TNGX icon
Tango Therapeutics
TNGX
+$4.7M

Sector Composition

Rank Sector Weight
1 Healthcare 56.77%
2 Financials 22.9%
3 Technology 12.32%
4 Consumer Discretionary 7.01%
5 Energy 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPLT icon
76
Katapult Holdings
KPLT
$31.6M
– –
-5,421
Closed -$6.51K
STWD icon
77
Starwood Property Trust
STWD
$6.16B
– –
-131,461
Closed -$2.64M
TRML
78
DELISTED
Tourmaline Bio
TRML
– –
-997,107
Closed -$15.9M
TEM
79
Tempus AI
TEM
$9.93B
– –
-80,167
Closed -$5.09M
RZLV
80
Rezolve AI
RZLV
$1.1B
– –
-181,667
Closed -$559K
1 2 3
4

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return
HPC
Highland Peak Capital Old Greenwich, Connecticut $373M AUM 80.02% 1-Year Est. Return

Blue Owl Capital Holdings's Q3 2025 Portfolio in Review

As of Q3 2025, Blue Owl Capital Holdings held 80 positions worth $322M, up 4% from $310M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Blue Owl Capital Holdings withdrew a net $21.1M in Q3 2025, closing 8 positions and reducing 12 holdings. Its most notable exit was Tourmaline Bio, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 51% a quarter earlier, followed by Financials and Technology.

Against the trend, Blue Owl Capital Holdings opened a new position in Roivant Sciences worth $15M.

  • Blue Owl Capital Holdings's largest Q3 2025 buy was Roivant Sciences: 988,249 shares worth $15M.
  • Blue Owl Capital Holdings added most to Ultragenyx Pharmaceutical in Q3 2025, an estimated $5.01M increase.
  • Blue Owl Capital Holdings's biggest Q3 2025 reduction was Nuveen Churchill Direct Lending, cutting an estimated $15.2M.
  • Blue Owl Capital Holdings fully exited Tourmaline Bio in Q3 2025, selling an estimated $15.9M.
  • Blue Owl Capital Holdings's ten largest holdings make up 62% of its $322M portfolio in Q3 2025.
  • Blue Owl Capital Holdings opened 8 new positions and closed 8 in Q3 2025.
  • Blue Owl Capital Holdings's portfolio value rose 4% quarter-over-quarter to $322M.

Based on Blue Owl Capital Holdings's 13F filing for Q3 2025, filed 12 Nov 2025.